Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development

FS PapeVeronika, A EnyedyÉva… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: During the past decades, thiosemicarbazones were clinically developed for a
variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard …

Metal complexes of thiosemicarbazones for imaging and therapy

JR Dilworth, R Hueting - Inorganica Chimica Acta, 2012 - Elsevier
This review gives an account of the coordination chemistry of thiosemicarbazone ligands
with three (tridentate) or four (tetradentate) potential donor atoms. The syntheses and …

New water-soluble copper (II) complexes with morpholine–thiosemicarbazone hybrids: Insights into the anticancer and antibacterial mode of action

K Ohui, E Afanasenko, F Bacher, RLX Ting… - Journal of medicinal …, 2018 - ACS Publications
Six morpholine-(iso) thiosemicarbazone hybrids HL 1–HL 6 and their Cu (II) complexes with
good-to-moderate solubility and stability in water were synthesized and characterized. Cu …

Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities

C Zhang, F Zhang - Protein & cell, 2015 - academic.oup.com
Excess iron is tightly associated with tumorigenesis in multiple human cancer types through
a variety of mechanisms including catalyzing the formation of mutagenic hydroxyl radicals …

Thiosemicarbazone derivatives developed to overcome COTI-2 resistance

V Pósa, A Stefanelli, JHB Nunes, S Hager, M Mathuber… - Cancers, 2022 - mdpi.com
Simple Summary Besides zinc, also iron and copper need to be considered to play a role in
the mode of action and resistance development of the anticancer thiosemicarbazone COTI-2 …

Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and …

A Popović-Bijelić, CR Kowol, MES Lind, J Luo… - Journal of inorganic …, 2011 - Elsevier
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone, 3-AP) is currently the most
promising chemotherapeutic compound among the class of α-N-heterocyclic …

Gallium complexes as new promising metallodrug candidates

JA Lessa, GL Parrilha, H Beraldo - Inorganica Chimica Acta, 2012 - Elsevier
This is a review article on non-radioactive gallium (III) complexes as new promising metal-
based drug candidates. A great variety of gallium (III) complexes and their pharmacological …

α− N− heterocyclic thiosemicarbazone Fe (III) complex: Characterization of its antitumor activity and identification of anticancer mechanism

Y Gou, J Wang, S Chen, Z Zhang, Y Zhang… - European Journal of …, 2016 - Elsevier
We synthesized an α− N− heterocyclic thiosemicarbazone ligand (L) and its Fe complex
(C1) and assessed their chemical and biological properties in order to understand their …

Reactivity of Cu(ii)–, Zn(ii)– and Fe(ii)–thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation

A Santoro, B Vileno, Ò Palacios, MD Peris-Díaz… - Metallomics, 2019 - academic.oup.com
Thiosemicarbazones (TSCs) are a class of strong metal ion ligands, which are currently
being investigated for several applications, such as anticancer treatment. In addition to these …

High copper complex stability and slow reduction kinetics as key parameters for improved activity, paraptosis induction, and impact on drug-resistant cells of …

S Hager, VFS Pape, V Pósa, B Montsch… - Antioxidants & redox …, 2020 - liebertpub.com
Aims: Due to their significant biological activity, thiosemicarbazones (TSCs) are promising
candidates for anticancer therapy. In part, the efficacy of TSCs is linked to their ability to …